| ADAMTS | A disintegrin and metalloproteinase with thrombospondin-1 domains |
| Caspase | Cyseinyl-aspartate specific proteinase |
| CASY | Cell counter and analyser system |
| DMMB | 1,9 Dimethylmethylene blue |
| ECM | Extracellular matrix |
| EDTA | Ethylenediaminetetraacetic acid |
| ER | Endoplasmatic reticulum |
| FDA | Food and Drug Administration |
| FCS | Fetal calf serum |
| sGAG | Sulfated glycosaminoglycan |
| IL | Interleukin |
| ITS | Insulin-transferrin-selenium |
| LDH | Lactate dehydrogenase |
| MAPK | mitogen-activated protein kinase |
| MMP | Matrix metalloproteinase |
| mTOR | Mechanistic target of rapamycin |
| mTORC | Mechanistic target of rapamycin complex |
| NF-κB | Nuclear factor κ-light-chain-enhancer of activated B-cells |
| NSAID | Nonsteroidal anti-inflammatory drugs |
| OA | Osteoarthritis |
| pS6 | Phospho-S6 |
| RT-PCR | Real time polymerase chain reaction |
| SOX | SRY-box |
| TNF | Tumor necrosis factor |
| TGF | Transforming growth factor |